[(18)F]Fluciclatide in the in vivo evaluation of human melanoma and renal tumors expressing α(v)β(3) and α(v)β(5) integrins

PURPOSE: [(18)F]Fluciclatide is an integrin-targeted PET radiopharmaceutical. α(v)β(3) and α(v)β(5) are upregulated in tumor angiogenesis as well as on some tumor cell surfaces. Our aim was to use [(18)F]fluciclatide (formerly known as [(18)F]AH111585) for PET imaging of angiogenesis in melanoma and...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Eur J Nucl Med Mol Imaging
Main Authors: Mena, Esther, Owenius, Rikard, Turkbey, Baris, Sherry, Richard, Bratslavsky, Gennady, Macholl, Sven, Miller, Matthew P., Somer, Ed J., Lindenberg, Liza, Adler, Stephen, Shih, Joanna, Choyke, Peter, Kurdziel, Karen
Formato: Artigo
Idioma:Inglês
Publicado em: 2014
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6336392/
https://ncbi.nlm.nih.gov/pubmed/24973039
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00259-014-2791-x
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados